| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Previous issue > Previous issue



Table of Contents | , 2006  Vol. 24  No.1 Previous Issue | Next Issue | Archive
In this issue:

Original Articles
Preliminary Results of Phase I/II Study of Simultaneous Modulated Accelerated (SMART) for Nasopharyngeal Carcinoma
Jin hong Park, Sang wook Lee, Geum Mun Back, Byong Yong Yi, Eun Kyung Choi, Seung Do Ahn, Seong Soo Shin, Jung hun Kim, Sang Yoon Kim, Bong Jae Lee, Soon Yuhl Nam, Seung Ho Choi, Seung Bae Kim, Sung Ho Park, Jong Hoon Kim
Radiat Oncol J. 2006;24(1):1-10.
PURPOSE: To present preliminary results of intensity-modulated radiotherapy (IMRT) using the simultaneous modulated accelerated radiation therapy (SMART) boost technique in patients with nasopharyngeal carcinoma (NPC). MATERIALS AND METHODS: Twenty patients who underwent IMRT for non-metastatic NPC at the Asan Medical Center between September 2001 and December 2003 were prospectively evaluated. IMRT was delivered using the "step and shoot" SMART technique at...
Locally Advanced, Unresectable Pancreatic Cancer Treated by Stereotactic Radiation Therapy
Chul Won Choi, Mi Sook Kim, Chul Koo Cho, Seong Yul Yoo, Kwang Mo Yang, Hyung Jun Yoo, Dong Han Lee, Young Hoon Ji, Chul Ju Han, Jin Kim, Young Han Kim
Radiat Oncol J. 2006;24(1):11-20.
PURPOSE: In order to find out whether stereotactic radiation therapy (RT) using CyberKnife (CK) could improve survival rate and lower acute toxicity compared to conventional RT. MATERIALS AND METHODS: From April 2003 through April 2004, 19 patients with Eastern Cooperative Oncology Group (ECOG) performance status < or =3 and locally advanced pancreas cancer without distant metastasis, evaluated by CT or PET/CT,...
Results of Preoperative Chemoradiotherapy in Low Rectal Cancer
Hyong Geun Yun
Radiat Oncol J. 2006;24(1):21-29.
PURPOSE: This study explored the anal sphincter-saving rate and down-staging rate after preoperative chemoradiotherapy for treating lower rectal cancer. We also explored the prognosis of the patients who refused surgery after preoperative chemoradiotherapy. MATERIALS AND METHODS: Thirty seven patients with histologically proven lower rectal cancer who underwent preoperative chemoradiotherapy were retrospectively analyzed. In each case, the tumor location was 0 to...
Relationship between XRCC1 Polymorphism and Acute Complication of Chemoradiation Therapy in the Patients with Colorectal Cancer
Woo Chul Kim, Yun Chul Hong, Sun Keun Choi, Ze Hong Woo, Jeong Hyun Nam, Gwang Seong Choi, Moon Hee Lee, Soon Ki Kim, Sun U Song, John JK Loh
Radiat Oncol J. 2006;24(1):30-36.
PURPOSE: It is well known from clinical experience that acute complications of chemoradiation therapy vary from patients to patients. However, there are no known factors to predict these acute complications before treatment starts. The human XRCC1 gene is known as a DNA base excision repair gene. We investigated the possibilities of XRCC1 gene polymorphisms as a predictor for the acute complications...
The Significance of VEGF Expression in Stage II Carcinoma of Uterine Cervix Treated with Definitive Radiotherapy
Won Park, Yoon La Choi, Seung Jae Huh, Sang Min Yoon, Young Je Park, Hee Rim Nam, Yong Chan Ahn, Do Hoon Lim, Hee Chul Park
Radiat Oncol J. 2006;24(1):37-43.
PURPOSE: We wanted to determine the clinical characteristics and prognosis according to the VEGF expression in stage II cervical carcinoma patients treated with definitive radiotherapy. MATERIALS AND METHODS: We enrolled 31 patients who were diagnosed with cervical cancer from 1995 to 2003 at Samsung Medical Center and their paraffin block tissue samples were available for study. The median age of the...
Rectal Complication Following Radical Radiotherapy in Carcinoma of the Uterine Cervix
Won Dong Kim, Woo Yoon Park
Radiat Oncol J. 2006;24(1):44-50.
PURPOSE: This study evaluated the late rectal complications in cervix cancer patients following treatment with external beam radiotherapy (EBRT) and high dose rate intracavitary radiation (HDR ICR). The factors affecting the risk of developing late rectal complications and its incidence were analyzed and discussed. MATERIALS AND METHODS: The records of 105 patients with cervix cancer who were treated with radical radiotherapy...
Intratumoral Administration of Dendritic Cells Combined with Hyperthermia Induces Both Local and Systemic Antitumor Effect in Murine Tumor Models
Byung Hyun Kwon, Won Taek Kim, Young Kan Ki, Dong Won Kim
Radiat Oncol J. 2006;24(1):51-57.
PURPOSE: We examined whether intratumoral (i.t.) administration of dendritic cells (DCs) into a treated tumor could induce local and systemic antitumor effects in a mouse tumor model. METHODS AND MATERIALS: C57BL/6 mice were inoculated s.c. in the right and left thighs with MCA-102 fibrosarcoma cells on day 0 and on day 7, respectively. On day 7, the tumors (usually 6 mm...
Radiation Induced Changes in the Expression of Fibronectin, Pai-1, MMP in Rat Glomerular Epithelial Cell
Woo Yoon Park, Won Dong Kim, Ying Zheng, Tae Sun Ha, Jae Sung Kim, Moon June Cho
Radiat Oncol J. 2006;24(1):58-66.
PURPOSE: Renal irradiation can lead to the development of radiation nephropathy, and this is characterized by the accumulation of extracellular matrix and final fibrosis. To determine the possible role of the glomerular epithelial cell, the radiation-induced changes in the expression of its genes associated with the extracellular matrix were analyzed. MATERIALS AND METHODS: Rat glomerular epithelial cells (GEpC) were irradiated ...
Effects of Recombinant Human Epidermal Growth Factor (rhEGF) on Experimental Radiation-Induced Oral Mucositis in Rats
Kwonil Jung, Sunhee Kim, Soo Young Moon, Yeon Wha Kim, Joon Pio Hong, Hyun Sook Kim, Sang wook Lee
Radiat Oncol J. 2006;24(1):67-76.
PURPOSE: Oral mucositis is a common toxicity of radiation or chemotherapy, which is used a treatment for head and neck cancer. We investigated effects of recombinant human epidermal growth factor (rhEGF) on radiation-induced oral mucositis in rat model. MATERIALS AND METHODS: Spraque-Dawley rats (7 per group) exposed to a single dose of 25 Gy (day 0) on their head, except for...
E-Submission
Principles of Transparency and Best Practice
Author's Index
KOSRO
Journal Impact Factor 1.8
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
Editorial Office
Department of Radiation Oncology, Samsung Medical Center,
Proton Therapy Center, B2, 81, Irwon-ro, Gangnam-gu, Seoul 06351, Republic of Korea
Tel : +82-2-3410-3617
E-mail: rojeditor@gmail.com, roj@kosro.or.kr
Copyright © The Korean Society for Radiation Oncology.                      Developed in M2PI
Close layer
prev next